| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |